Do you routinely use prophylactic anticoagulation when treating ovarian cancer patients with neoadjuvant chemotherapy?
Community PollStarted
Which anticoagulation strategy do you most often employ for patients on NAC for HGSOC?
74 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Gynecologic Oncology · Cooper Medical School of Rowan University
Answered on
There are currently no standard guidelines regarding VTE prophylaxis in patients undergoing neoadjuvant chemotherapy (NACT) for ovarian cancer. ASCO recommends against routine use for patients receiving chemotherapy who are at average risk, but "suggest" prophylaxis in patients at high risk.
Retrospe...
Join for free or sign in to see the full answer